"False"
Umeå University
printicon
Main menu hidden.
Staff photo Erik Håkansson

Erik Håkansson

Cardiologist at the Umeå Heart Centre, focused on heart failure. PhD-student since 2021 investigating usage of SGLT2-inhibitors.

0000-0003-1545-178X

Contact

E-mail
erik.hakansson@umu.se
Phone

Works at

Affiliation
Affiliated as research student at Department of Public Health and Clinical Medicine
Location
Byggnad 1A, plan 4, målpunkt B41, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin
European Journal of Clinical Pharmacology, Springer Nature 2024, Vol. 80, (9) : 1363-1371
Norberg, Helena; Andersson, Therese; Håkansson, Erik; et al.
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study
Open heart, BMJ Publishing Group Ltd 2022, Vol. 9, (2)
Håkansson, Erik; Brunström, Mattias; Norberg, Helena; et al.
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
Cardiovascular Therapeutics, Hindawi Publishing Corporation 2021, Vol. 2021
Håkansson, Erik; Norberg, Helena; Själander, Sara; et al.
View publications in DiVA